1) Alakus H, Batur M, Schmidt M, et al:Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun 31:532-538, 2010
2) Hess KR, Abbruzzese MC, Lenzi R, et al:Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 5:3403-3410, 1999
3) Holmes FF, Fouts TL:Metastatic cancer of unknown primary site. Cancer 26:816-820, 1970
4) Iizuka Y, Iizuka H, Tsutsumi S, et al:Diagnosis of a previously unidentified primary site in patients with spinal metastasis:diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy. Eur Spine J 18:1431-1435, 2009
5) Kwon JY, Yun J, Kim HJ, et al:Clinical outcome of gastric cancer patients with bone marrow metastases. Cancer Res Treat 43:244-249, 2011
6) Liang T, Wan Y, Zou X, et al:Is surgery for spine metastasis reasonable in patients older than 60 years ? Clin Orthop Relate Res 471:628-639, 2013
7) 西川和孝,今澤良精,河村誠一・他:癌の脊椎手術によるADL障害に対する手術治療成績.整外と災外58:394-398,2009
8) Pavlidis N, Briasoulis E, Hainsworth J, et al:Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39:1990-2005, 2003
9) Tomita K, Kawahara N, Kobayashi T, et al:Surgical strategy for spinal metastases. Spine (PhilaPa 1976) 26:298-306, 2001
10) Uchida K, Nakajima H, Miyazaki T, et al:(18)F-FDG PET/CT for Diagnosis of osteosclerotic and osteolytic vertebral metastatic lesions:comparison with bone scintigraphy. Asian Spine J 7:96-103, 2013